国家药监局局长李利会见新加坡卫生科学局局长蔡瑞文

Core Points - The meeting between the heads of the National Medical Products Administration of China and the Health Sciences Authority of Singapore focused on enhancing mutual trust in drug and medical device regulation [1] - Both parties agreed to deepen practical cooperation in the field of drug regulation to improve the quality and efficiency of drug oversight [1] - The collaboration aims to better promote the health and well-being of the people in both countries [1]